Humab is looking for partners seeking to develop new antibody drugson the SynThese™ platform which allows for finding the most optimized antibodyin the shortest period of time.
HuMab | CEO : Changkyu Oh | 202, 38, Magokjungang 8-ro 1-gil, Gangseo-gu, Seoul, Republic of Korea (07793)
TEL : +82) 2-6956-0390 | E-mail :
Copyright © 휴맵. All Rights Reserved.